(Q34594956)

English

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

phase II clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metastatic adenocarcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S-E Al-Batran

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

J T Hartmann

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

R Hofheinz

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

N Homann

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

V Rethwisch

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

S Probst

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

J Stoehlmacher

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

M R Clemens

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

R Mahlberg

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

M Fritz

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

G Seipelt

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

M Sievert

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

C Pauligk

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

A Atmaca

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

E Jäger

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

31 July 2008

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1882-1887

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Advances in the treatment of patients with gastric adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Mitomycin C, 5-fluorouracil, leucovorin, and oxaliplatin as a salvage therapy for patients with cisplatin-resistant advanced gastric cancer: a phase I dose escalation trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDN403

21 January 2018

Identifiers

10.1093/ANNONC/MDN403

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

release_2m444jpgxzay5dwylxcrgpndtu

1 reference

https://api.fatcat.wiki/v0/release/2m444jpgxzay5dwylxcrgpndtu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34594956&oldid=1844572317"